A carregar...

Future treatments for hereditary hemorrhagic telangiectasia

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Rendu-Osler syndrome, is a genetic vascular disorder affecting 1 in 5000–8000 individuals worldwide. This rare disease is characterized by various vascular defects including epistaxis, blood vessel dilations (telangiectasia) and arteriovenou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: Robert, Florian, Desroches-Castan, Agnès, Bailly, Sabine, Dupuis-Girod, Sophie, Feige, Jean-Jacques
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945546/
https://ncbi.nlm.nih.gov/pubmed/31910860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-019-1281-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!